AliveDx announces US FDA 510 submission for MosaiQ AiPlex® Celiac Disease multiplex microarray

AliveDx Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America Europe California

View original content:https://www.prnewswire.co.uk/news-releases/alivedx-announces-us-fda-510k-submission-for-mosaiq-aiplex-celiac-disease-cd-multiplex-microarray-302371523.html